Quintrio
Home

BLANK CHECKS

Launch One Acquisition Corp. Class A Ordinary shares

LPAA

Launch One Acquisition Corp is a blank check company.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $10.86 – $11.05
Volume 8
Market cap $83M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for LPAA.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for LPAA.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Minovia Therapeutics announced the grant of two new U.S. patents (No. 12,502,408 and No. 12,329,781) covering its proprietary Mitochondrial Augmentation Therapy (MAT) platform for treating primary mitochondrial diseases and renal diseases. The patents, with corresponding grants in Europe and Japan, strengthen the company's intellectual property portfolio. Minovia's lead program MNV-201, currently in clinical trials for Pearson Syndrome, consists of autologous hematopoietic stem cells enriched with placental-derived mitochondria. The company is proceeding with a business combination with Launch One Acquisition Corp., expected to close in the first half of 2026.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.